Your Comments On...

U.S. to Buy Anthrax Treatment From HGS

Human Genome Sciences Inc. is scheduled to announce today that the federal government has agreed to buy $165 million worth of an experimental treatment for anthrax infection in what will become the 14-year-old Rockville firm's first product sale.
 - 

By Michael S. Rosenwald

 
Comments
© 2006 The Washington Post Company